SC
ANGO icon

Scotia Capital’s AngioDynamics ANGO Stock Holding History

Scotia Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,147
Closed -$130K – 907
2025
Q2 		$130K Sell
13,147
-1,102
-8% -$10.8K ﹤0.01% 818
2025
Q1 		$134K Buy
+14,249
New +$150K ﹤0.01% 804

Other funds holding ANGO

DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Scotia Capital's ANGO Position: Q3 2025 in Review

Scotia Capital sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 13,147 shares — an estimated $130K sold.

Scotia Capital first reported a position in ANGO in Q1 2025 and held it in 2 quarters. The position peaked at $134K in Q1 2025. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Scotia Capital reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Scotia Capital sold 13,147 AngioDynamics shares in Q3 2025, an estimated $130K.
  • Scotia Capital first reported a position in AngioDynamics in Q1 2025 and held it in 2 quarters.
  • Scotia Capital's AngioDynamics position peaked at $134K in Q1 2025.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Scotia Capital's 13F filing for Q3 2025, filed 14 Nov 2025.